Align Technology, Inc. (NASDAQ:ALGN) noted a jump in its shares Friday, on announcing the new Cone Beam Computed Tomography (CBCT) integration feature for ClinCheck digital treatment planning software, a user-friendly tool that combines roots, bone, and crowns into a single three-dimensional model that enables doctors to visualize a patient’s roots as part of the digital treatment planning process.
The Tempe, Arizona-based ALGN, boasts a status as a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry.
Friday’s news release goes on to say the CBCT integration feature helps doctors confidently expand diagnosis and treat a broader range of cases with Invisalign clear aligners by increasing visibility and control of a patient’s underlying anatomical structures during the digital treatment planning process.
Said one ALGN official, “In an easy-to-use interface, CBCT scan data is digitally fused with an intraoral scan resulting into a maneuverable 3D ClinCheck treatment plan model, thus making it convenient for doctors to tailor their treatment plans based on their patients’ needs.
"We are pleased to deliver a high-quality, automated feature that is easy for doctors to use and incorporate into their digital workflow. Our innovative technology delivers treatment plans with a highly intuitive user interface that allows doctors to provide the best possible care for their patients."
ALGN shares opened Friday up $2.82 to $428.30
